Is Cannabinol legal in Finland?

Legal status

Controlled only as a constituent, and not on its own name. Cannabinol is not named in any annex of valtioneuvoston asetus huumausaineina pidettävistä aineista, valmisteista ja kasveista 543/2008, not named in the annex to valtioneuvoston asetus 1130/2014, and not named in annex 1, annex 1 A or annex 2 of the medicines list 230/2025, as those annexes stand after 651/2026, 1119/2025 and 650/2026. What is named, in Liite I under list I of the 1961 Single Convention, is «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat», so a cannabis extract or tincture containing cannabinol is caught by that entry while isolated cannabinol is not reached by a name of its own. Section 1 of the medicines list decision states in terms «Lääkeaineluettelo ei ole tyhjentävä.», which the live Finland cell also quoted, so absence from annex 1 does not decide the medicine question either.

Consequences if caught

Capital exposure: none. No penalty is asserted for this entry as a class, because the classification itself is unresolved. Chapter 50 of the Criminal Code (39/1889) carries the narcotics offences. Section 1 sets a fine or up to two years for a huumausainerikos covering manufacture, cultivation, import, export, transport, sale, supply, distribution and possession. Section 2 sets one to ten years for a törkeä huumausainerikos where the object is a very dangerous narcotic or a large quantity, or substantial gain is sought, or the act is part of an organised group, or serious danger to life or health is caused to several people, or the drug is spread to minors. Section 2 a sets a fine or up to six months for a huumausaineen käyttörikos, unlawful use or possession of a small quantity for own use. Section 3 sets a fine or up to two years for preparation and section 4 the same for promotion, while section 4 a sets four months to six years for aggravated promotion. Section 7 allows the charge or the sentence to be waived where the quantity, the circumstances and the use situation make the act minor as a whole, or where the suspect has entered approved treatment. Criminal Code chapter 44 section 5 a carries the separate consumer market offence. It sets a fine or up to one year for manufacturing, importing, storing, keeping for sale or transferring a psychoactive substance banned from the consumer market, contrary to the Narcotics Act. Possession for one's own use and use itself are not among the acts it names. The live Finland cell recorded the same three provisions and asserted no custodial term at all, and every provision it named is carried here: Criminal Code (39/1889) chapter 50, the substantive prohibitions in Narcotics Act 373/2008 section 5 with the lawful exceptions in section 3, and the consumer market conduct offence in Criminal Code chapter 44 section 5 a. The bands stated above are new to this pass and were read off the Criminal Code itself, not carried from that cell. Whether the offence reaches this row at all is exactly what was not established here. This row in particular. The entry this row is reached through sits in Liite I, which the decree heads as the substances and preparations in the lists of the 1961 Single Convention on Narcotic Drugs, under list I of that annex, at printed position 67 of the 145 entries that list carries in the consolidated text read here, it reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat», and it is that entry rather than this row's own name that the decree prints. In the printed order of that list the entry above it is Isotonitatsepyyni and below it comes Karfentaniili. The same list closes by extending itself beyond its named entries, in the words «tässä luettelossa mainittuja aineita sisältävät valmisteet lukuun ottamatta luettelossa III mainittuja valmisteita.». The annex that carries this row stands as amended by 25.6.2026/651, which is the amendment that last touched this row's annex rather than the decree as a whole. Section 5 subsection 1 of huumausainelaki 373/2008 is the prohibition that placement engages, «Huumausaineen tuotanto, valmistus, tuonti Suomen alueelle, vienti Suomen alueelta, kuljetus, kauttakuljetus, jakelu, kauppa, käsittely, hallussapito ja käyttö on kielletty.», and chapter 50 section 5 subsection 1 of the Criminal Code makes the word huumausaine in those offences mean a narcotic under huumausainelaki, so the annex entry above is what puts this row inside them. Criminal Code chapter 50 section 2 a is the small quantity limb and it opens «Joka laittomasti käyttää taikka omaa käyttöä varten pitää hallussaan tai yrittää hankkia vähäisen määrän huumausainetta, on tuomittava», so the käyttörikos reaches this row on its own terms. No quantity figure is printed anywhere in chapter 50: whether a quantity is a suuri määrä, and whether the substance is an erittäin vaarallinen huumausaine under chapter 50 section 5 subsection 2, are findings of fact and the annex position does not settle either of them. No fine figure is printed either, because a Finnish fine is a day fine set on the offender's income.

If prescribed or medical

No authorised cannabinol medicine is identified for this row. Where a substance is a medicinal ingredient rather than a listed narcotic, it is handled through the Medicines Act 395/1987, in particular the conduct and import rules in section 3 and the medicinal substances list, and its status turns on individual product classification. This row in particular. The entry this row is reached through sits in list I of the 1961 Convention annex, and section 24 of huumausainelaki 373/2008 reaches exactly that: it disapplies the import and export provisions of the Act for medicinal products containing a substance in lists I to III of the 1961 Convention or lists II to IV of the 1971 Convention, the products being those «joita matkustaja käyttää henkilökohtaiseen lääkitykseensä», and then hands the traveller to section 19 of lääkelaki 395/1987. That reading is about the entry, not about this row's own name, which the decree does not print. Whether a product containing this row falls inside the carve out follows from what the product contains, and this cell does not settle it.

Documentation

Carry any prescribed medicine in its dispensed packaging with the prescription. Finland's personal import rules for medicines sit in the Medicines Act 395/1987 and were not read for this cell, so no traveller allowance is stated here. This row in particular. The locator a traveller or an official would be checking is Liite I list I entry 67 of 543/2008, as that annex stands after 25.6.2026/651, and the entry printed there reads «Kannabis, kannabishartsi sekä kannabisuutteet ja -tinktuurat». Because the row is in that part of the convention annexes, section 24 of huumausainelaki 373/2008 takes a traveller's own prescribed medicine out of the Act's import and export provisions and leaves section 19 of lääkelaki 395/1987 to govern how much may be carried, which is the provision this cell did not read. Provenance for this row. The consolidated 543/2008 read here is the Finlex text carrying amendments up to 25.6.2026/651, the version Finlex identifies as data.finlex.fi/eli/sd/2008/543/ajantasa/2026-06-26/fin, in force from 10 July 2026, read on 21 September 2026; the consolidated 1130/2014 read here is the Finlex text whose annex was substituted by 650/2026 with effect from 10 July 2026, read on 21 September 2026; and where the medicines list is cited it is the Finnish annex text to decision 230/2025 served by Finlex, read on 21 September 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Finland’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.